India to United States: Ezetimibe Export Trade Route

The India to United States Ezetimibe corridor is one of India's established pharmaceutical export routes, with 418 shipments documented worth a combined $221.5M USD. The route is dominated by PIRAMAL PHARMA LIMITED, which alone accounts for roughly 49% of all export value, reflecting the consolidated nature of India's ezetimibe manufacturing sector.

Across 15 active suppliers, the average shipment value stands at $530.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with ezetimibe's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 13.6%, placing it at rank #17 among India's top ezetimibe export destinations globally.

On the import side, key buyers of Indian ezetimibe in United States include PCI PHARMA SERVICES, ASCEND LABORATORIES LLC, ASCEND LABORATORIES,LLC and 31 others. PCI PHARMA SERVICES is the single largest importer with 24 shipments valued at $108.2M USD.

India's ezetimibe exports to United States are driven primarily by a handful of large-scale manufacturers. PIRAMAL PHARMA LIMITED with 50 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 15 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — PIRAMAL PHARMA LIMITED, ALKEM LABORATORIES LIMITED, ZYDUS LIFESCIENCES LIMITED — together account for 97% of total trade value on this route. The average shipment value of $530.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as ezetimibe tablets usp 10mg (each tab cont. ezetimibe usp 10mg) [12009 pack x 500's] (batch no. 23123421, 23123626, 23123 and ezetimibe tablets usp 10mg (each tab cont. ezetimibe usp 10mg) [7416 pack x 500's] (batch no. 23123672, 23123673 mfg dt., suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, PCI PHARMA SERVICES is the largest importer with 24 shipments worth $108.2M USD — representing 49% of all ezetimibe imports from India on this route. A total of 34 buyers are active on this corridor.